Free Trial

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
$0.35
-2.5%
$0.44
$0.31
$0.75
$18.10M-0.11207,717 shs158,879 shs
Appreciated Media Holdings Inc. stock logo
AMEFF
Appreciated Media
$0.02
+6.8%
$0.02
$0.01
$0.05
N/AN/A63,600 shs37,900 shs
ANGHW
Anghami
$0.04
+29.6%
$0.05
$0.01
$0.11
N/AN/A7,834 shs1,946 shs
Bally Technologies stock logo
BYI
Bally Technologies
$0.00
$56.50
$84.66
N/AN/A839,983 shsN/A
WildBrain Ltd. stock logo
WLDBF
WildBrain
$0.73
-3.9%
$0.81
$0.70
$1.55
N/AN/A62,722 shs33,600 shs
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
0.00%-5.97%-10.57%-8.35%-18.65%
Appreciated Media Holdings Inc. stock logo
AMEFF
Appreciated Media
0.00%0.00%0.00%0.00%0.00%
ANGHW
Anghami
0.00%-12.50%+0.33%-19.95%-39.92%
WildBrain Ltd. stock logo
WLDBF
WildBrain
0.00%-5.19%-7.62%-21.42%-50.34%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
N/AN/AN/AN/AN/AN/AN/AN/A
Appreciated Media Holdings Inc. stock logo
AMEFF
Appreciated Media
N/AN/AN/AN/AN/AN/AN/AN/A
ANGHW
Anghami
N/AN/AN/AN/AN/AN/AN/AN/A
Bally Technologies stock logo
BYI
Bally Technologies
N/AN/AN/AN/AN/AN/AN/AN/A
WildBrain Ltd. stock logo
WLDBF
WildBrain
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
N/AN/AN/AN/A
Appreciated Media Holdings Inc. stock logo
AMEFF
Appreciated Media
N/AN/AN/AN/A
ANGHW
Anghami
N/AN/AN/AN/A
Bally Technologies stock logo
BYI
Bally Technologies
N/AN/AN/AN/A
WildBrain Ltd. stock logo
WLDBF
WildBrain
N/AN/A$3.00310.96% Upside

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
$193K93.79N/AN/A$0.20 per share1.77
Appreciated Media Holdings Inc. stock logo
AMEFF
Appreciated Media
N/AN/AN/AN/AN/AN/A
ANGHW
Anghami
$41.38MN/AN/AN/AN/AN/A
Bally Technologies stock logo
BYI
Bally Technologies
N/AN/AN/AN/AN/AN/A
WildBrain Ltd. stock logo
WLDBF
WildBrain
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
-$28.96M-$0.64N/AN/A-16,123.32%-191.38%-128.26%N/A
Appreciated Media Holdings Inc. stock logo
AMEFF
Appreciated Media
N/AN/A0.00N/AN/AN/AN/AN/A
ANGHW
Anghami
N/AN/A0.00N/AN/AN/AN/AN/A
Bally Technologies stock logo
BYI
Bally Technologies
N/AN/A0.00N/AN/AN/AN/AN/AN/A
WildBrain Ltd. stock logo
WLDBF
WildBrain
N/AN/A0.00N/AN/AN/AN/AN/A

Latest WLDBF, AIM, ANGHW, AMEFF, and BYI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/16/2024Q1 2024
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
N/A-$0.12-$0.12-$0.12N/A$0.04 million
3/29/2024Q4 2023
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
N/A-$0.26-$0.26-$0.26N/A$0.07 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
N/AN/AN/AN/AN/A
Appreciated Media Holdings Inc. stock logo
AMEFF
Appreciated Media
N/AN/AN/AN/AN/A
ANGHW
Anghami
N/AN/AN/AN/AN/A
Bally Technologies stock logo
BYI
Bally Technologies
N/AN/AN/AN/AN/A
WildBrain Ltd. stock logo
WLDBF
WildBrain
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
0.23
1.14
1.14
Appreciated Media Holdings Inc. stock logo
AMEFF
Appreciated Media
N/AN/AN/A
ANGHW
Anghami
N/AN/AN/A
Bally Technologies stock logo
BYI
Bally Technologies
N/AN/AN/A
WildBrain Ltd. stock logo
WLDBF
WildBrain
N/AN/AN/A

Ownership

Institutional Ownership

CompanyInstitutional Ownership
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
12.02%
Appreciated Media Holdings Inc. stock logo
AMEFF
Appreciated Media
N/A
ANGHW
Anghami
N/A
Bally Technologies stock logo
BYI
Bally Technologies
N/A
WildBrain Ltd. stock logo
WLDBF
WildBrain
N/A

Insider Ownership

CompanyInsider Ownership
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
0.02%
Appreciated Media Holdings Inc. stock logo
AMEFF
Appreciated Media
N/A
ANGHW
Anghami
N/A
Bally Technologies stock logo
BYI
Bally Technologies
N/A
WildBrain Ltd. stock logo
WLDBF
WildBrain
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
2651.28 million51.27 millionNot Optionable
Appreciated Media Holdings Inc. stock logo
AMEFF
Appreciated Media
N/AN/AN/ANot Optionable
ANGHW
Anghami
146N/AN/ANot Optionable
Bally Technologies stock logo
BYI
Bally Technologies
N/AN/AN/ANot Optionable
WildBrain Ltd. stock logo
WLDBF
WildBrain
613N/AN/ANot Optionable

WLDBF, AIM, ANGHW, AMEFF, and BYI Headlines

Recent News About These Companies

WILDBRAIN REPORTS Q3 2024 RESULTS
WildBrain Ltd WLDBF
Online Auctions
WildBrain GAAP EPS of -C$0.08, revenue of C$105.5M
Guest Chef Takeover
Parenting News
Parts of the Brain
Psychology News
Addiction News
WildBrain Ltd (Common & Variable Voting)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

AIM ImmunoTech logo

AIM ImmunoTech

NYSE:AIM
AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's lead product candidate is Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome (CFS). It is also developing Ampligen for the treatment of pancreatic, renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, and prostate cancers, as well as for myalgic encephalomyelitis, Hepatitis B, HIV, COVID-19, and post-COVID conditions. In addition, the company provides Alferon N Injection, an injectable formulation of natural alpha interferon to treat human papilloma viruses, and genital warts, a sexually transmitted disease. AIM ImmunoTech Inc. has agreements with Amarex Clinical Research LLC; University of Cagliari Dipartimento di Scienze della Vita e dell'Ambiente; Jubilant HollisterStier; Sterling Pharma Solutions; Erasmus University Medical Center Rotterdam; Azenova, LLC; and Alcami Corporation. The company was formerly known as Hemispherx Biopharma, Inc. and changed its name to AIM ImmunoTech Inc. in August 2019. AIM ImmunoTech Inc. was incorporated in 1966 and is headquartered in Ocala, Florida.
Appreciated Media logo

Appreciated Media

OTCMKTS:AMEFF
Appreciated Media Holdings, Inc. is a worldwide film and television media production packager. It engages in producing independent films, made-for-television movies, and TV series for global B2B distribution. The company was founded by Kirk Edward Shaw, Tony Zhang, and Norman Tsui on October 1, 2014 and is headquartered in Hamilton, Canada.

Anghami

NASDAQ:ANGHW
Anghami Inc. operates a digital music entertainment technology platform in the Middle East and North Africa. It offers digital entertainment and online streaming services, including music, podcasts, music videos, and live events; and a music application and platform that provides Arabic and international music to stream and download. The company was founded in 2012 and is headquartered in Abu Dhabi, the United Arab Emirates.
Bally Technologies logo

Bally Technologies

NYSE:BYI
Bally Technologies, Inc. (Bally) is a global gaming company, which designs, manufactures, operates, and distributes advanced technology-based gaming devices, systems, server-based solutions, custom mobile applications, and interactive applications. The Company also provides hardware, including spinning-reel and video gaming devices, specialty gaming devices, and wide-area progressive systems. The Company supports customers include land-based, riverboat, and Native American casinos, video lottery and central determination markets. The Company derives its revenue from sale of gaming devices and related equipment, parts and conversion kits; operation of linked progressive systems, video lottery and centrally determined systems, and the rental of gaming devices and content, and sale and support of specialized systems-based software, hardware and interactive products and related recurring maintenance revenue. In July 2014, Bally Technologies Inc acquired Dragonplay Ltd. (Dragonplay).
WildBrain logo

WildBrain

OTCMKTS:WLDBF
WildBrain Ltd. develops, produces, and distributes films and television programs in Canada, the United States, the United Kingdom, and internationally. The company operates through two segments, Content and Canadian Television Broadcasting. It focuses on children's and family content, including animated series; provides content production and distribution services; and operates children's ad-supported video-on-demand (AVOD) channels on YouTube and other AVOD platforms. The company also licenses rights of new proprietary series or pre-sells shows that are in development to individual streaming services, broadcasters, and other media platforms; and re-licenses rights of existing series in the library or packages of programs of its own proprietary titles, as well as third-party produced titles. In addition, it holds broadcast licenses for Family Channel, Family Jr., Télémagino, and WildBrain TV television channels; and operates as entertainment, sport, and brand licensing agency for the company's own and third party brands. Further, the company licenses its brands, such as Peanuts, Strawberry Shortcake, Chip and Potato, Teletubbies, Yo Gabba Gabba!, Caillou, Johnny Test, In the Night Garden, Mattel on Bob the Builder, Fireman Sam, Little People, Polly Pocket, Degrassi, and Inspector Gadget, as well as publishing, music rights, and live tours. Additionally, it offers its films and television programs for streaming services; and conventional and specialty terrestrial and cable/satellite television broadcasters, as well as for other media platforms and digital providers. The company was formerly known as DHX Media Ltd. and changed its name to WildBrain Ltd. in December 2019. WildBrain Ltd. was incorporated in 2004 and is headquartered in Toronto, Canada.